Oregon health care providers and pharmacies may resume administering the Johnson & Johnson COVID-19 vaccine if they can ensure patients or their caregivers are informed about the benefits and risks of the vaccine in their primary language. The Oregon Health Authority issued guidance to health care providers earlier today. Currently, there are approximately 124,000 doses of the Johnson & Johnson vaccine that have been stored at Oregon vaccination sites, while providers awaited resolution of the recent federal and Western States safety reviews. On April 13, the federal Centers for Disease Control and Prevention (CDC) recommended a pause on use of the Johnson & Johnson vaccine following reports of rare and serious blood clots in a small number of people, out of the approximately 7.5 million people who'd been vaccinated at the time. Yesterday, the Food and Drug Administration lifted the pause, with a warning about the potential for rare blood clots for women under age 50.
Apr 25, 2021
oregon health authority
Oregon health care providers and pharmacies may resume administering the Johnson & Johnson COVID-19 vaccine if they can ensure patients or their caregivers are informed about the benefits and risks of the vaccine in their primary language.
The Oregon Health Authority issued guidance to health care providers earlier today. Currently, there are approximately 124,000 doses of the Johnson & Johnson vaccine that have been stored at Oregon vaccination sites, while providers awaited resolution of the recent federal and Western States safety reviews.
On April 13, the federal Centers for Disease Control (CDC) recommended a pause on use of the Johnson & Johnson vaccine following reports of rare and serious blood clots in a small number of people, out of the approximately 7.5 million people who’d been vaccinated at the time.
Johnson & Johnson COVID vaccine OK d for Oregon use soon April 24 2021
The Western States Scientific Safety Review Workgroup gave the thumbs up following approval from the Centers for Disease Control and Prevention.
Jabs of the Johnson & Johnson novel coronavirus vaccine will soon return to Oregonians arms despite the death of one state resident whose blood clotted following injection after a multi-state review board gave the all-clear.
The Western States Scientific Safety Review Workgroup, comprised of scientists and health leaders from Oregon, California, Nevada and Washington, confirmed on Saturday, April 24, a prior federal re-approval of the Johnson & Johnson shot.
The ball now rests with the Oregon Health Authority, which is expected to promptly issue a plan to doctors and other vaccine providers for resumption of the vaccine s use and distribution in Oregon soon.